HLA-A*02:01 CMV pp65 Tetramer-NLVPMVATV-BV421

Catalog No:
MBL-TS-0010-4C
$1,575.00

Formerly Catalog No.: TB-0010-4

Description

Product Description

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

Product Specifications
Application FC
Reactivity Human
Conjugation BV421
Peptide Sequence NLVPMVATV
Class Class I
MHC Allele A*02:01

Documents & Links

Documents & Links for HLA-A*02:01 CMV pp65 Tetramer-NLVPMVATV-BV421
Datasheet HLA-A*02:01 CMV pp65 Tetramer-NLVPMVATV-BV421 Datasheet

Documents & Links for HLA-A*02:01 CMV pp65 Tetramer-NLVPMVATV-BV421
Datasheet HLA-A*02:01 CMV pp65 Tetramer-NLVPMVATV-BV421 Datasheet

Product Description

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

Product Specifications
Application FC
Reactivity Human
Conjugation BV421
Peptide Sequence NLVPMVATV
Class Class I
MHC Allele A*02:01

Documents & Links

Documents & Links for HLA-A*02:01 CMV pp65 Tetramer-NLVPMVATV-BV421
Datasheet HLA-A*02:01 CMV pp65 Tetramer-NLVPMVATV-BV421 Datasheet

Documents & Links for HLA-A*02:01 CMV pp65 Tetramer-NLVPMVATV-BV421
Datasheet HLA-A*02:01 CMV pp65 Tetramer-NLVPMVATV-BV421 Datasheet